Remember Moderna? It is one of the United States government preferred companies that made big money off the vehement push for virtually every person in America to take their experimental coronavirus “vaccine” shots promoted under the deceptive description of “safe and effective.”
With that grab for profits having largely petered out, it looks like the US government is back to help Moderna along with subjecting Americans to Moderna’s new experimental mRNA flu shots. In a Thursday report on the matter, journalist Alex Berenson provided a one-word summation of the trial results Moderna has provided to US regulators in the effort to obtain approval for the shots: “awful.” Further wrote Berenson:
The trial showed severe side effects from the mRNA shot dwarfed whatever protection against flu it may offer.
Compared to a standard flu shot, the mRNA jab prevented about 1 hospitalization in every 5,000 people who received it.1 But compared to the standard shot, the mRNA jab caused severe after-injection side effects such as vomiting or a 102- to 104-degree fever in an extra 1 out of 18 people.
In other words, Moderna’s own data show that about 270 people will suffer severe vaccine side effects from its shot to stop a single flu hospitalization. In what world does that risk ratio make sense?2
The trial also showed that more people who received the mRNA shot died from all causes in the next six months than those who got the standard jab.
Read Berenson’s complete report here.
Berenson also explained in his report that Moderna’s new mRNA flu shots’ path to regulatory approval would have been blocked earlier but for the forced resignation in March of Vinay Prasad from the position of chief medical officer of the Food and Drug Administration (FDA) “largely because of pressure from Moderna — and Blackstone, the giant private equity company that has invested $750 million into Moderna’s mRNA flu shot.”
Interestingly, on Friday news broke that President Donald Trump, who in his first term as president launched Operation Warp Speed that made Moderna its first fortune, has signed off on a plan to fire the top person at the FDA — Commissioner Marty Makary.
Will the Moderna mRNA flu shot achieve approval via political string pulling? That result would be yet another indication that the Make America Healthy Again movement at the Department of Health and Human Services, where the FDA resides, is being consumed by the swamp that Trump used to be fond of promising to drain.